Zentalis PharmaceuticalsL Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Zentalis PharmaceuticalsL Company Summary

Zentalis PharmaceuticalsL competes with Codexis, Calyxt, Cumberland Pharmaceuticals, AcelRx Pharmaceuticals, and Avadel Pharmaceuticals. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. The company was incorporated in 2014 and is based in New York, New York. Zentalis Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 177 people.

Zentalis PharmaceuticalsL Key Financial Ratios

Generally speaking, Zentalis PharmaceuticalsL's financial ratios allow both analysts and investors to convert raw data from Zentalis PharmaceuticalsL's financial statements into concise, actionable information that can be used to evaluate the performance of Zentalis PharmaceuticalsL over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Zentalis PharmaceuticalsL reports annually and quarterly.

Zentalis Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Zentalis PharmaceuticalsL's current stock value. Our valuation model uses many indicators to compare Zentalis PharmaceuticalsL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zentalis PharmaceuticalsL competition to find correlations between indicators driving Zentalis PharmaceuticalsL's intrinsic value. More Info.Zentalis PharmaceuticalsLlc is rated below average in net income category among related companies. It is rated below average in debt to equity category among related companies . Zentalis PharmaceuticalsL Net Income is quite stable at the moment as compared to the past year. The company's current value of Net Income is estimated at (243.04 Million). Comparative valuation analysis is a catch-all model that can be used if you cannot value Zentalis PharmaceuticalsL by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Zentalis PharmaceuticalsL's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zentalis PharmaceuticalsL's earnings, one of the primary drivers of an investment's value.

Zentalis PharmaceuticalsL Systematic Risk

What exactly are Zentalis PharmaceuticalsL Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Zentalis PharmaceuticalsL's income statement, its balance sheet, and the statement of cash flows. Potential Zentalis PharmaceuticalsL investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Zentalis PharmaceuticalsL investors may use each financial statement separately, they are all related. The changes in Zentalis PharmaceuticalsL's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Zentalis PharmaceuticalsL's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Zentalis PharmaceuticalsL is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Zentalis has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Along with financial statement analysis, the daily predictive indicators of Zentalis PharmaceuticalsL help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zentalis PharmaceuticalsLlc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zentalis PharmaceuticalsLlc based on widely used predictive technical indicators. In general, we focus on analyzing Zentalis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zentalis PharmaceuticalsL's daily price indicators and compare them against related drivers.

Check out Your Current Watchlist. For more information on how to buy Zentalis Stock please use our How to buy in Zentalis Stock guide. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

When running Zentalis PharmaceuticalsL price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.

Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine Zentalis PharmaceuticalsL value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.